Suppression of Inflammation-Associated Kidney Damage Post-Transplant Using the New PrC-210 Free Radical Scavenger in Rats
Open Access
- 19 July 2021
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 11 (7) , 1054
Abstract
Allograft kidney transplantation, which triggers host cellular- and antibody-mediated rejection of the kidney, is a major contributor to kidney damage during transplant. Here, we asked whether PrC-210 would suppress damage seen in allograft kidney transplant. Brown Norway (BN) rat kidneys were perfused in situ (UW Solution) with or without added 30 mM PrC-210, and then immediately transplanted into Lewis (LEW) rats. 20 h later, the transplanted BN kidneys and LEW rat plasma were analyzed. Kidney histology, and kidney/serum levels of several inflammation-associated cytokines, were measured to assess mismatch-related kidney pathology, and PrC-210 protective efficacy. Twenty hours after the allograft transplants: (i) significant histologic kidney tubule damage and mononuclear inflammatory cell infiltration were seen in allograft kidneys; (ii) kidney function metrics (creatinine and BUN) were significantly elevated; (iii) significant changes in key cytokines, i.e., TIMP-1, TNF-alpha and MIP-3A/CCL20, and kidney activated caspase levels were seen. In PrC-210-treated kidneys and recipient rats, (i) kidney histologic damage (Banff Scores) and mononuclear infiltration were reduced to untreated background levels; (ii) creatinine and BUN were significantly reduced; and (iii) activated caspase and cytokine changes were significantly reduced, some to background. In conclusion, the results suggest that PrC-210 could provide broadly applicable organ protection for many allograft transplantation conditions; it could protect transplanted kidneys during and after all stages of the transplantation process—from organ donation, through transportation, re-implantation and the post-operative inflammation—to minimize acute and chronic rejection.Keywords
Funding Information
- National Institutes of Health (R03CA176799)
- UW Inst Clin Translational Research (UL1TR002373)
This publication has 27 references indexed in Scilit:
- Expression of MMP-2 and TIMP-1 in Renal Tissue of Patients with Chronic Active Antibody-mediated Renal Graft RejectionDiagnostic Pathology, 2012
- A New Orally Active, Aminothiol Radioprotector-Free of Nausea and Hypotension Side Effects at Its Highest Radioprotective DosesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Synthesis and growth regulatory activity of a prototype member of a new family of aminothiol radioprotectorsBioorganic & Medicinal Chemistry Letters, 2011
- Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and NonadherenceAmerican Journal of Transplantation, 2011
- Delayed Graft Function in the Kidney TransplantAmerican Journal of Transplantation, 2011
- De Novo Donor-Specific Antibody at the Time of Kidney Transplant Biopsy Associates with Microvascular Pathology and Late Graft FailureAmerican Journal of Transplantation, 2009
- PresensitizationClinical Journal of the American Society of Nephrology, 2006
- A Comparison of Plasmapheresis Versus High-Dose IVIG Desensitization in Renal Allograft Recipients with High Levels of Donor Specific AlloantibodyAmerican Journal of Transplantation, 2006
- Evidence for mitochondrial DNA damage by lipid peroxidationBiochemical and Biophysical Research Communications, 1988
- Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation productsJournal of Biochemical and Biophysical Methods, 1984